Zdrowie i gospodarka · 07/10/2015

FDA Corrects Notice on Fee for Using Rare Pediatric Disease Priority Review Voucher in Fiscal Year 2016

The FDA is correcting a notice regarding the fee for using a rare pediatric disease priority review voucher for fiscal year 2016, which was published with an incorrect docket number. The corrected document was published to rectify the error.